- Home
- MEDP vs VFS Comparison
MEDP vs VFS Comparison
Compare MEDP & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- VFS
- Stock Information
- Founded
- MEDP 1992
- VFS 2017
- Country
- MEDP United States
- VFS Vietnam
- Employees
- MEDP N/A
- VFS N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- VFS Blank Checks
- Sector
- MEDP Health Care
- VFS Finance
- Exchange
- MEDP Nasdaq
- VFS Nasdaq
- Market Cap
- MEDP 10.5B
- VFS 9.0B
- IPO Year
- MEDP 2016
- VFS N/A
- Fundamental
- Price
- MEDP $287.85
- VFS $2.80
- Analyst Decision
- MEDP Buy
- VFS Strong Buy
- Analyst Count
- MEDP 10
- VFS 3
- Target Price
- MEDP $373.22
- VFS $8.00
- AVG Volume (30 Days)
- MEDP 428.9K
- VFS 488.7K
- Earning Date
- MEDP 04-21-2025
- VFS 04-24-2025
- Dividend Yield
- MEDP N/A
- VFS N/A
- EPS Growth
- MEDP 42.23
- VFS N/A
- EPS
- MEDP 12.63
- VFS N/A
- Revenue
- MEDP $2,109,054,000.00
- VFS $1,517,342,313.00
- Revenue This Year
- MEDP $4.45
- VFS N/A
- Revenue Next Year
- MEDP $9.67
- VFS $57.08
- P/E Ratio
- MEDP $24.08
- VFS N/A
- Revenue Growth
- MEDP 11.84
- VFS 64.54
- 52 Week Low
- MEDP $289.01
- VFS $2.26
- 52 Week High
- MEDP $459.77
- VFS $6.42
- Technical
- Relative Strength Index (RSI)
- MEDP 32.73
- VFS 31.05
- Support Level
- MEDP $295.22
- VFS $3.15
- Resistance Level
- MEDP $311.99
- VFS $3.40
- Average True Range (ATR)
- MEDP 10.53
- VFS 0.17
- MACD
- MEDP -2.32
- VFS -0.03
- Stochastic Oscillator
- MEDP 8.41
- VFS 1.65
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Automobiles, E-scooter, Spare parts & Aftermarket services. The Automobiles segment includes the design, development, manufacturing, and sales of cars and electric buses; The E-scooter segment includes the design, development, manufacturing, and sales of e-scooters; the Spare parts & Aftermarket services segment includes the sales of spare parts and rendering of aftermarket services for automobiles and e-scooters.